Table of Content




1. Executive Summary


2. Global Central Nervous System Biomarker Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Central Nervous System Biomarker Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Central Nervous System Biomarker Market by Type
3.3.1: Safety Biomarkers
3.3.2: Efficacy Biomarkers
3.3.3: Validation Biomarkers
3.3.4: Others


3.4: Global Central Nervous System Biomarker Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Personalized Medicine
3.4.3: Others

3.5: Global Central Nervous System Biomarker Market by End Use
3.5.1: Diagnostic Labs
3.5.2: Clinics & Hospitals
3.5.3: Research Centers
3.5.4: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Central Nervous System Biomarker Market by Region
4.2: North American Central Nervous System Biomarker Market

4.2.2: North American Central Nervous System Biomarker Market by End Use: Diagnostic Labs, Clinics & Hospitals, Research Centers, and Others

4.3: European Central Nervous System Biomarker Market
4.3.1: European Central Nervous System Biomarker Market by Type: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, and Others

4.3.2: European Central Nervous System Biomarker Market by End Use: Diagnostic Labs, Clinics & Hospitals, Research Centers, and Others

4.4: APAC Central Nervous System Biomarker Market
4.4.1: APAC Central Nervous System Biomarker Market by Type: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, and Others

4.4.2: APAC Central Nervous System Biomarker Market by End Use: Diagnostic Labs, Clinics & Hospitals, Research Centers, and Others

4.5: ROW Central Nervous System Biomarker Market
4.5.1: ROW Central Nervous System Biomarker Market by Type: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, and Others

4.5.2: ROW Central Nervous System Biomarker Market by End Use: Diagnostic Labs, Clinics & Hospitals, Research Centers, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Central Nervous System Biomarker Market by Type
6.1.2: Growth Opportunities for the Global Central Nervous System Biomarker Market by Application
6.1.3: Growth Opportunities for the Global Central Nervous System Biomarker Market by End Use

6.1.4: Growth Opportunities for the Global Central Nervous System Biomarker Market by Region

6.2: Emerging Trends in the Global Central Nervous System Biomarker Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Central Nervous System Biomarker Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Central Nervous System Biomarker Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Acumen Pharmaceuticals
7.2: Alseres Pharmaceuticals
7.3: Avacta Life Sciences
7.4: Biomeriux
7.5: Bio-Rad Laboratories
7.6: G-Biosciences
7.7: Merck